Table: Towa Pharmaceutical -2021/22 group results

TOWA PHARMACEUTICAL

13/05/2022 07:00

May 13 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            165.62          154.90         212.50        101.50   
                 (+6.9 pct)      (+40.3 pct)    (+28.3 pct)  (+23.4 pct) 
  Operating         19.21           19.92          19.00          8.00   
                 (-3.6 pct)      (+23.4 pct)    (-1.1 pct)   (-22.4 pct) 
  Recurring         22.74           18.68          19.00          8.00   
                 (+21.7 pct)     (-11.0 pct)    (-16.4 pct)  (-38.5 pct) 
  Net
  Net               15.91           13.96          12.00          4.00   
                 (+14.0 pct)     (-3.8 pct)     (-24.6 pct)  (-56.7 pct) 
  EPS            323.36 yen      283.62 yen     243.79 yen    81.26 yen  
  EPS Diluted    316.19 yen      271.93 yen                              
  Ann Div         60.00 yen       44.00 yen      60.00 yen               
  -Q2 Div         27.00 yen       22.00 yen      30.00 yen               
  -Q4 Div         33.00 yen       22.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T